MedPath
FDA Approval

Tavaborole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 1, 2022
Labeling Type
Human Prescription Drug Label
Tavaborole(43.5 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Encube Ethicals Private Limited

Encube Ethicals Private Limited

725076298

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tavaborole

Product Details

NDC Product Code
21922-020
Application Number
ANDA211297
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
October 29, 2020
Code: K124A4EUQ3Class: ACTIBQuantity: 43.5 mg in 1 mL
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
EDETATE CALCIUM DISODIUMInactive
Code: 25IH6R4SGFClass: IACT
© Copyright 2025. All Rights Reserved by MedPath